US Stock MarketDetailed Quotes
TAK Takeda Pharmaceutical
- 13.380
- +0.050+0.38%
Close Nov 22 16:00 ET
- 13.380
- 0.0000.00%
Post 20:01 ET
42.57BMarket Cap22.72P/E (TTM)
13.420High13.300Low1.56MVolume13.330Open13.330Pre Close20.85MTurnover0.05%Turnover Ratio45.36P/E (Static)3.18BShares15.08052wk High0.95P/B40.74BFloat Cap12.57552wk Low0.31Dividend TTM3.05BShs Float20.357Historical High2.30%Div YieldTTM0.90%Amplitude11.568Historical Low13.378Avg Price1Lot Size
Takeda Pharmaceutical Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 41.25%280.96B | 84.31%170.3B | -26.69%716.34B | -5.14%278.59B | -61.28%146.45B | -9.99%198.91B | 9.68%92.4B | -13.00%977.16B | -21.80%293.69B | 8.84%378.23B |
| Net income from continuing operations | 292.01%92.11B | 6.59%95.3B | -54.52%144.2B | -109.62%-2.99B | -11.24%105.76B | -177.71%-47.97B | -14.87%89.41B | 37.74%317.04B | 373.71%31.14B | 106.07%119.15B |
| Operating gains losses | 134.50%757M | -674.37%-3.43B | -550.25%-8.25B | -3,827.22%-7.07B | -63.84%413M | -419.36%-2.19B | 224.46%597M | -77.63%1.83B | -104.77%-180M | -18.66%1.14B |
| Depreciation and amortization | 5.34%192.45B | 12.08%192.22B | 9.57%728B | 15.70%186.74B | 5.76%187.06B | 8.86%182.7B | 8.35%171.5B | 13.93%664.4B | 6.00%161.41B | 20.10%176.88B |
| Deferred tax | 156.79%27.27B | -9.47%41.3B | -257.46%-91.41B | -365.38%-44.53B | -270.92%-44.5B | -1,804.26%-48.01B | -9.56%45.63B | -19.82%58.05B | 139.32%16.78B | -183.46%-12B |
| Other non cash items | 30.46%54.7B | -133.98%-80.77B | 789.71%160.2B | 208.01%80.88B | 0.98%71.91B | -38.99%41.93B | 26.62%-34.52B | -90.23%18.01B | -188.54%-74.89B | 19.57%71.21B |
| Change In working capital | -4,553.46%-70.81B | 46.87%-80.19B | -913.31%-256B | -58.59%59.38B | -423.60%-166.02B | 105.05%1.59B | 19.91%-150.95B | -125.62%-25.26B | -19.75%143.39B | -28.36%51.3B |
| -Change in receivables | -158.03%-10.04B | 47.17%-47.74B | -79.90%15.1B | 8.24%73.9B | 11.88%14.29B | 43.44%17.29B | -402.91%-90.37B | -40.98%75.13B | 51.54%68.27B | -90.71%12.77B |
| -Change in inventory | 16.64%-41.14B | 64.75%-10.08B | -46.22%-115.74B | 128.38%12.75B | -173.82%-50.55B | -640.98%-49.35B | -213.54%-28.59B | -71.52%-79.16B | -552.83%-44.92B | -29.08%-18.46B |
| -Change in payables and accrued expense | 102.50%376M | -8.08%-37.46B | 88.33%-9.9B | -150.66%-30.48B | 1,011.24%70.27B | 62.57%-15.02B | 64.32%-34.66B | -167.76%-84.8B | -52.61%60.17B | -206.42%-7.71B |
| -Change in other current liabilities | -396.04%-26.42B | -64.50%8.96B | -158.63%-18.57B | -121.61%-8.55B | -210.03%-44.19B | 327.89%8.92B | 157.20%25.25B | 163.84%31.67B | 2,453.23%39.58B | 176.97%40.16B |
| -Change in other working capital | -83.88%6.41B | 127.10%6.12B | -497.82%-126.9B | -42.01%11.77B | -734.91%-155.83B | 454.57%39.75B | -12.32%-22.58B | 154.91%31.9B | 69.00%20.29B | 472.67%24.54B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 41.25%280.96B | 84.31%170.3B | -26.69%716.34B | -5.14%278.59B | -61.28%146.45B | -9.99%198.91B | 9.69%92.4B | -13.00%977.16B | -21.80%293.69B | 8.84%378.23B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -24.02%-75.13B | 41.21%-156.69B | 23.59%-463.86B | 85.98%-61.49B | -61.20%-75.27B | -122.66%-60.58B | -181.41%-266.53B | -206.42%-607.1B | -1,610.32%-438.49B | 32.47%-46.69B |
| Net PPE purchase and sale | -67.49%-49.44B | -25.00%-57.43B | -19.41%-166.81B | -27.65%-44.53B | -39.82%-46.81B | -0.98%-29.52B | -9.16%-45.95B | -15.03%-139.7B | -2.08%-34.89B | -23.78%-33.48B |
| Net intangibles purchase and sale | -33.49%-42.98B | 64.01%-80.36B | 38.08%-305.31B | 95.15%-19.79B | -75.09%-30.04B | -184.64%-32.2B | -296.94%-223.28B | -685.27%-493.03B | -2,413.61%-408.31B | 19.66%-17.16B |
| Net business purchase and sale | 77,085.71%5.39B | 690.59%2.94B | 150.80%19.96B | 146.22%19.59B | --0 | ---7M | --372M | 137.06%7.96B | -69.46%7.96B | --0 |
| Net investment purchase and sale | 615.71%7.75B | -20,018.32%-26.36B | -364.77%-32.05B | -844.17%-28.41B | -242.39%-2B | -114.36%-1.5B | -104.04%-131M | 41.06%12.1B | -2,716.52%-3.01B | -29.20%1.41B |
| Net other investing changes | -434.59%-711M | -92.86%-27M | -31.19%-4B | -38.37%-3.92B | -83.85%63M | 65.36%-133M | 93.78%-14M | 58.35%-3.05B | -7.11%-2.83B | 111.50%390M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -24.02%-75.13B | 41.21%-156.69B | 23.59%-463.86B | 85.98%-61.48B | -61.21%-75.27B | -122.67%-60.58B | -181.41%-266.53B | -206.42%-607.1B | -1,610.32%-438.49B | 32.47%-46.69B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 21.76%-110.04B | 647.58%316.38B | 50.02%-354.42B | -782.03%-58.22B | 77.52%-97.76B | -171.14%-140.65B | 73.22%-57.78B | 33.74%-709.15B | 97.29%-6.6B | -158.81%-434.96B |
| Net issuance payments of debt | 55.72%-69.55B | 332.35%429.61B | 100.53%1.51B | -149.19%-14.28B | 127.61%73.49B | -1,358.81%-157.07B | 367.62%99.37B | 52.53%-285.07B | 115.70%29.02B | -678.82%-266.2B |
| Net common stock issuance | --0 | 19.09%-1.88B | 91.36%-2.33B | --0 | --0 | --0 | 91.36%-2.33B | 65.27%-26.93B | --0 | --0 |
| Cash dividends paid | -1.48%-9.2B | -5.63%-138.11B | -2.78%-287.19B | 12.41%-9.13B | -7.18%-138.25B | 18.58%-9.07B | -1.45%-130.75B | 1.50%-279.42B | 2.09%-10.42B | 1.87%-128.99B |
| Net other financing activities | -108.07%-4.47B | 1,091.92%42.23B | 470.06%33.96B | -308.68%-13.13B | 31.98%-4.03B | 213,084.62%55.38B | -26,506.25%-4.26B | -2,283.64%-9.18B | -17,750.00%-3.21B | -1,572.88%-5.92B |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 21.76%-110.05B | 647.58%316.38B | 50.02%-354.42B | -782.17%-58.22B | 77.52%-97.76B | -171.14%-140.66B | 73.22%-57.78B | 33.74%-709.15B | 97.29%-6.6B | -158.81%-434.96B |
| Net cash flow | ||||||||||
| Beginning cash position | 154.44%805.01B | -14.19%457.8B | -37.21%533.53B | -57.91%288.36B | -60.15%318.05B | -51.02%316.38B | -37.21%533.53B | -12.06%849.7B | -5.41%685.14B | 31.30%798.14B |
| Current changes in cash | 4,212.80%95.79B | 242.29%329.99B | 69.94%-101.93B | 204.94%158.88B | 74.30%-26.58B | -101.64%-2.33B | -2.53%-231.91B | -133.40%-339.09B | -242.63%-151.4B | -193.75%-103.42B |
| Effect of exchange rate changes | -1,144.60%-41.78B | 16.67%17.22B | 14.28%26.2B | 5,081.13%10.56B | 67.48%-3.12B | -60.92%4B | -34.36%14.76B | -20.27%22.93B | -101.10%-212M | -255.83%-9.58B |
| End cash Position | 170.09%859.02B | 154.44%805.01B | -14.19%457.8B | -14.19%457.8B | -57.91%288.36B | -60.15%318.05B | -51.02%316.38B | -37.21%533.53B | -37.21%533.53B | -5.41%685.14B |
| Free cash flow | 46.29%188.51B | 118.38%32.51B | -31.40%235.61B | 242.47%214.26B | -78.84%69.33B | -28.56%128.86B | -1,151.06%-176.84B | -63.35%343.47B | -146.45%-150.39B | 9.54%327.61B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
